Irrational use of skin-bleaching products can delay the diagnosis of leprosy [1]

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 70, Issue 2, 2002, Pages 119-121

  Mahe, Antoine ^a,d   Ly, Fatimata ^a   Badiane, Charles ^b   Balde, Yaya ^b   Dangou, Jean Marie ^c  

^a Institut dHygiene Sociale Dakar   (Senegal)

^b Institut de Leprologie Appliquee Dakar   (Senegal)

^c INSTITUT PASTEUR DE DAKAR   (Senegal)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEACHING AGENT; CLOBETASOL PROPIONATE; HYDROQUINONE; MOVATE; SKIN LIGHT;

ADULT; BIOPSY; BLEACHING; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; LEPROSY; LETTER; RISK FACTOR; SKIN DEFECT; TREATMENT PLANNING; TUBERCULOID LEPROSY;

ADMINISTRATION, TOPICAL; ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CHEEK; CLOBETASOL; DERMATOLOGIC AGENTS; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROQUINONES; LEPROSY, BORDERLINE; SKIN; THIGH;

EID: 0036637905     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Nephrotic syndrome in adult Africans in Nairobi
2. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams
3. Skin lighteners cause permanent damage
4. Unregulated use of clobetasol propionate
5. Enquěte épidémiologique sur l'utilisation cosmétique de produits dépigmentants par les femmes de Bamako (Mali)